Characterization of diabetic peripheral neuropathy in a high-fat diet mouse model
Abstract
Diabetic peripheral neuropathy (DPN) is characterized by progressive and symmetrical sensory alterations and constitutes one of the earliest and main complications of diabetes. Several mouse models have been developed to mimic the pathogenesis of DPN with some discrepancies to fully recapitulate the human disease. In the present study, we aimed to characterize the onset and progression of peripheral neuropathy in mice fed with 45% kcal High Fat Diet (HFD) for 16 weeks. Our data show that mice fed with this diet developed obesity, dyslipidemia, hyperglycemia, impaired glucose tolerance and insulin resistance. Using sensory tests, we found that HFD-fed mice developed mechanical hypoalgesia and thermal hyperalgesia starting after 12 weeks of diet. Our analysis of glabrous foot skin innervation revealed a decrease in intraepidermal nerve fiber density (IENFD) associated with a significant reduction of nociceptive Schwann cells (nSCs) in neuropathic mice after 16 weeks of HFD. Overall, this study shows that mice fed with a 45% kcal HFD recapitulate the main metabolic, behavioral and anatomical changes generally observed in patients with DPN and represent a reliable model to study the pathogenesis of the disease.
Related
- Tyrosyl-tRNA sequestration triggers tyrosyl-tRNA synthetase-associated peripheral neuropathy
- Extracellular vesicle-mediated restraint of hepatic CD74–NF-κB repairs diabetic neuropathy
- Degraded myelin is associated with cold hypersensitivity in paclitaxel-induced peripheral neuropathy
- Biallelic PIGB Variants Cause Motor Neuropathy with Conduction Blocks and Peripheral Nerve Hyperexcitability
- Machine-assisted systematic review and meta-analysis of citrus flavonoids in streptozotocin-induced painful diabetic neuropathy
BibTeX
@article{rastoldo2026characterization,
title = {{Characterization of diabetic peripheral neuropathy in a high-fat diet mouse model}},
author = {Guillaume Rastoldo and Alexis Chirpaz and Sarrah Tréport and Anne-Yael Gamin and Ali Jaafar and Aurélie Paulo-Ramos and Thomas Sandaye and Katy Thouvenot and Matthieu Bringart and Marie-Paule Gonthier and Gilles Lambert and Steeve Bourane},
journal = {PLoS ONE},
year = {2026},
month = sep,
doi = {10.1371/journal.pone.0356285},
url = {https://hal.science/hal-05739407v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Characterization of diabetic peripheral neuropathy in a high-fat diet mouse model
AU - Guillaume Rastoldo
AU - Alexis Chirpaz
AU - Sarrah Tréport
AU - Anne-Yael Gamin
AU - Ali Jaafar
AU - Aurélie Paulo-Ramos
AU - Thomas Sandaye
AU - Katy Thouvenot
AU - Matthieu Bringart
AU - Marie-Paule Gonthier
AU - Gilles Lambert
AU - Steeve Bourane
PY - 2026
DA - 2026/09/01
JO - PLoS ONE
DO - 10.1371/journal.pone.0356285
UR - https://hal.science/hal-05739407v1
AB - Diabetic peripheral neuropathy (DPN) is characterized by progressive and symmetrical sensory alterations and constitutes one of the earliest and main complications of diabetes. Several mouse models have been developed to mimic the pathogenesis of DPN with some discrepancies to fully recapitulate the human disease. In the present study, we aimed to characterize the onset and progression of peripheral neuropathy in mice fed with 45% kcal High Fat Diet (HFD) for 16 weeks. Our data show that mice fed with this diet developed obesity, dyslipidemia, hyperglycemia, impaired glucose tolerance and insulin resistance. Using sensory tests, we found that HFD-fed mice developed mechanical hypoalgesia and thermal hyperalgesia starting after 12 weeks of diet. Our analysis of glabrous foot skin innervation revealed a decrease in intraepidermal nerve fiber density (IENFD) associated with a significant reduction of nociceptive Schwann cells (nSCs) in neuropathic mice after 16 weeks of HFD. Overall, this study shows that mice fed with a 45% kcal HFD recapitulate the main metabolic, behavioral and anatomical changes generally observed in patients with DPN and represent a reliable model to study the pathogenesis of the disease.
SN - 1932-6203
SN - 1932-6203
ER -